Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Shionogi
Pharma
Eisai, BeiGene, Shionogi—Fierce Pharma Asia
Eisai fields lecanemab safety questions in its full data release. BeiGene's Brukinsa betas Imbruvica in CLL. Shionogi's COVID drug snags first nod.
Angus Liu
Dec 2, 2022 10:00am
ViiV Healthcare finds HIV stigma still stubbornly high
Dec 2, 2022 9:40am
Shionogi drug to compete with Paxlovid and Lagevrio in Japan
Nov 22, 2022 11:18am
Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia
Sep 30, 2022 9:15am
COVID-19 tracker: Pfizer, AstraZeneca, Moderna and more
Aug 31, 2022 11:15am
Biocon, AstraZeneca, Shionogi—Fierce Pharma Asia
Jun 24, 2022 9:10am
